Monoclonal Antibodies in Eosinophilic COPD Safely Reduce Exacerbations
Treating eosinophilic COPD with monoclonal antibodies significantly reduces exacerbations vs standard care, with an acceptable safety profile.
Treating eosinophilic COPD with monoclonal antibodies significantly reduces exacerbations vs standard care, with an acceptable safety profile.
The United States spends more on health care than any similarly large and wealthy country. However, in 2023, Americans had a life expectancy of 78.4…
Image Challenge from the New England Journal of Medicine — February 20, 2025
This year’s final rule from CMS provided the long-expected but unwelcome news of a 2.8% cut in the 2025 Medicare conversion factor.
American Thoracic Society
Ensifentrine is a promising supplementary therapeutic option in the management of COPD.
Audio Interview from the New England Journal of Medicine — Interview with Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs…
New guidelines on central airway obstruction standardize diagnosis and management recommendations, emphasizing therapeutic bronchoscopy, rigid bronchoscopy, and multidisciplinary care.
Medicaid is the primary program providing comprehensive coverage of health care and long-term services and supports to more than 90 million low-income people in the…
European Respiratory Society. 36,086 likes · 245 talking about this. With members in over 100 countries, the European Respiratory Society (ERS) aims to alleviate sufferi
Background: In pediatric patients, the intracuff pressure of endotracheal tubes should be as low as possible to prevent injury to the tracheal mucosal wall. The…